Evaluating Cancer Care Networks; A Case Study of a Lung Cancer Care Network

Document Type : Original Article


1 Rijnstate, Arnhem, The Netherlands

2 Alliantie Regionale Topzorg (A.R.T.Z.), Arnhem, The Netherlands

3 Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands

4 Netherlands Cancer Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands

5 Slingeland Hospital, Doetinchem, The Netherlands

6 Ziekenhuis Gelderse Vallei, Ede, The Netherlands


Networks are promoted as an organizational form that enables integrated care as well as enhanced patient outcomes. However, implementing networks is complex. It is therefore important to evaluate the quality and effectiveness of networks to ensure it is worth developing and maintaining them. This article describes the development of an evaluation tool for cancer care networks and the results of a pilot study with a regional lung cancer care network.
This study used a combination of qualitative and quantitative evaluation methods. The qualitative evaluation was based on a framework with 10 standards for the organization of an oncological (tumor-specific) care network. Data for the quantitative evaluation were obtained from the Dutch Cancer Registry. The evaluation was performed at a network of three hospitals collaborating in the field of lung oncology.
The qualitative evaluation framework consisted of 10 standards/questions which were divided into 38 subquestions. The evaluation showed that in general patients are satisfied with the collaboration in the network. However, some improvement points were found such as the need for more attention for the implementation and periodic evaluation of a regional care pathway. The start of a regional multidisciplinary meeting has been a major step for improving the collaboration.
An evaluation tool for (lung) cancer care networks was successfully developed and piloted within a cancer care network. The tool has proven to be a useful method for evaluating collaboration within an oncological network. It helped network partners to understand what they see as important and allowed them to learn about their program’s dynamics. Improvement opportunities were successfully identified. To keep the tool up to date continuous improvement is needed, following the Plan Do Check Act (PDCA) cycle.


  1. Provan KG, Beagles JE, Leischow SJ. Network formation, governance, and evolution in public health: the North American Quitline Consortium case. Health Care Manage Rev. 2011;36(4):315-326. doi:1097/HMR.0b013e31820e1124
  2. Provan KG, Fish A, Sydow J. Interorganizational networks at the network level: a review of the empirical literature on whole networks. J Manage. 2007;33(3):479-516. doi:1177/0149206307302554
  3. Calman K, Hine D. A Policy Framework for Commissioning Cancer Services: A Report by the Expert Advisory Group on Cancer to the Chief Medical Officers of England and Wales. London: Department of Health; 1995.
  4. Tremblay D, Touati N, Roberge D, et al. Understanding cancer networks better to implement them more effectively: a mixed methods multi-case study. Implement Sci. 2016;11:39. doi:1186/s13012-016-0404-8
  5. Pieters W, Schuurbiers O, Huijgens P, Limbeek R. Oncologienetwerk goed alternatief voor concentratie. Medisch Contact; 2014.
  6. Taskforce Oncologie, IKNL, Levenmetkanker, et al. 2015/2020 Koersboek Oncologische Netwerkvorming. Houten, the Netherlands.
  7. Ferlie E, Fitzgerald L, McGivern G, Dopson S, Bennett C. Making Wicked Problems Governable?: The Case of Managed Networks in Health Care. Oxford, UK: Oxford University Press; 2013. doi:1093/acprof:oso/9780199603015.001.0001
  8. Popp J, MacKean G, Casebeer A, Milward H, Lindstrom R. Inter-Organizational Networks: A Review of the Literature to Inform Practice. Washington, DC: IBM Center for the Business of Government; 2013.
  9. Lega F, Sartirana M. Managed clinical networks: scope, evidence and feasibility. Int J Clin Pract. 2011;65(7):725-727. doi:1111/j.1742-1241.2011.02686.x
  10. Carswell P, Manning B, Long J, Braithwaite J. Building clinical networks: a developmental evaluation framework. BMJ Qual Saf. 2014;23(5):422-427. doi:1136/bmjqs-2013-002405
  11. Miller RL. Developing standards for empirical examinations of evaluation theory. Am J Eval. 2010;31(3):390-399. doi:1177/1098214010371819
  12. Stake RE, Scriven M. The methodology of evaluation. In: Stake RE, ed. Curriculum Evaluation. Chicago, US: Rand McNally; 1967.
  13. Stufflebeam DL, Madaus GF, Kellaghan T. The CIPP model for evaluation. In: Stufflebeam DL, Madaus GF, Kellaghan T, eds. Evaluation Models: Viewpoints on Educational and Human Services Evaluation. Boston, US: Kluwer Academic Publishers; 2003:31-62.
  14. Patton MQ. Utilization-Focused Evaluation. Los Angeles, US: SAGE Publications; 2008.
  15. Rossi P, Lipsey M, Freeman H. Evaluation: A Systematic Approach. Los Angeles, US: SAGE Publications; 2003.
  16. Stichting Oncologische Samenwerking. Multidisciplinaire Normering Oncologische Zorg in Nederland. SONCOS; 2012: Normeringsrapport 1. https://www.soncos.org/wp-content/uploads/2018/08/Multidisciplinaire-normeringdocument-definitief.pdf. Accessed December 22, 2020.
  17. Integraal Kankercentrum Nederland (IKNL). Kwaliteitskader Organisatie Oncologische Zorg. IKNL; 2014.
  18. Integraal Kankercentrum Nederland (IKNL). Tumorspecifiek Kwaliteitskader Longcarcinoom. IKNL; 2016.
  19. Stichting Oncologische Samenwerking. Multidisciplinaire Normering Oncologische Zorg in Nederland. SONCOS; 2018: Normeringsrapport 6. https://www.soncos.org/wp-content/uploads/2017/10/46SONCOS-standardisation-report.pdf. Accessed January 10, 2020.
  20. Intergraal Kankercentrum Nederland. Nederlands Kanker Registratie (NKR). 2020. https://www.iknl.nl/nkr. Accessed March 12, 2020.
  21. Rami-Porta R, Giroux D, Goldstraw P. The new TNM classification of lung cancer in practice. Breathe. 2011;7(4):348-360. doi:1183/20734735.000111
  22. Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11(1):39-51. doi:1016/j.jtho.2015.09.009
  23. Integraal Kankercentrum Nederland. About IKNL. 2020. https://www.iknl.nl/en. Accessed March 13, 2020.
  24. Zhang Y, Wildemuth BM. Qualitative analysis of content. In: Wildemuth BM, ed. Applications of Social Research Methods to Questions in Information and Library Science. Westport, US: Libraries Unlimited; 2009.
  25. Wood JC, Wood MC. Edwards Deming: Critical Evaluations in Business and Management. Vol 2. Abingdon, US: Taylor & Francis US; 2005.
  26. Nederlandse Federatie van Kankerpatiënten organisaties (NFK). Een Ziekenhuis Kiezen Bij Kanker: Wat Vind Jij Belangrijk? Doneer Je Ervaring Rapportage. NFK; 2019.
  27. Evans-Lacko S, Jarrett M, McCrone P, Thornicroft G. Facilitators and barriers to implementing clinical care pathways. BMC Health Serv Res. 2010;10:182. doi:1186/1472-6963-10-182
  28. van Oosten M. Echelonnering van het MDO. Oncologie. 2018;9(3):1-2.
Volume 11, Issue 10
October 2022
Pages 2103-2114
  • Receive Date: 01 July 2020
  • Revise Date: 21 June 2021
  • Accept Date: 04 August 2021
  • First Publish Date: 05 September 2021